​

Enliven Therapeutics (ELVN) Revenue & Revenue Breakdown

OverviewForecastFinancialsChart

Enliven Therapeutics Revenue Highlights

00

Enliven Therapeutics Revenue by Period

Enliven Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Enliven Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Enliven Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$440.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Enliven Therapeutics generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Enliven Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
KRONKronos Bio$6.29M$2.37M
INBXInhibrx Biosciences$1.80M-
LYRALyra Therapeutics$1.56M$195.00K
CGEMCullinan Oncology--
GPCRStructure Therapeutics--
IMRXImmuneering--
GOSSGossamer Bio-$9.48M
AVTEAerovate Therapeutics--
REPLReplimune Group--
PMVPPMV Pharmaceuticals--
CELCCelcuity--
NVCTNuvectis Pharma--
ELVNEnliven Therapeutics--
CMPXCompass Therapeutics--
MLTXMoonLake Immunotherapeutics--

ELVN Revenue FAQ

What is Enliven Therapeutics’s yearly revenue?

Enliven Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. ELVN's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Enliven Therapeutics’s quarterly revenue?

Enliven Therapeutics's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). ELVN's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Enliven Therapeutics’s revenue growth rate?

Enliven Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.